$32.91
-1.69[-4.88%]
At close: Apr 18
$32.91
0[0.00%]
PreMarket: 9:20AM EDT
Belite Bio
(NASDAQ:BLTE)Belite Bio Stock (NASDAQ:BLTE), Analyst Ratings, Price Targets, Predictions
Belite Bio Inc has a consensus price target of $48.8, established from looking at the 20 latest analyst ratings. The last 3 analyst ratings were released from HC Wainwright & Co., HC Wainwright & Co., and HC Wainwright & Co. on March 22, 2024, March 13, 2024, and December 27, 2023. With an average price target of $59 between HC Wainwright & Co., HC Wainwright & Co., and HC Wainwright & Co., there's an implied 79.28% upside for Belite Bio Inc from these 3 analyst ratings.
Analyst Firms Making Recommendations1
HC Wainwright & Co.
Maxim Group
Benchmark
Cantor Fitzgerald
SVB Leerink
1calculated from analyst ratings published within the last 3 years
Analyst Ratings for Belite Bio
date | ticker | Buy Now | Company | Current price | Upside/Downside | Analyst Firm | Analyst & % Accurate | Price Target Change | Rating Change | Previous / Current Rating | Get Alert |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 03/22/2024 | BLTE | Buy Now | Belite Bio | $32.91 | 79.28% | HC Wainwright & Co. | Yi Chen | $59 → $59 | Maintains | Buy | Get Alert |
| 03/13/2024 | BLTE | Buy Now | Belite Bio | $32.91 | 79.28% | HC Wainwright & Co. | Yi Chen | → $59 | Reiterates | Buy → Buy | Get Alert |
| 12/27/2023 | BLTE | Buy Now | Belite Bio | $32.91 | 79.28% | HC Wainwright & Co. | Yi Chen | → $59 | Reiterates | Buy → Buy | Get Alert |
| 12/14/2023 | BLTE | Buy Now | Belite Bio | $32.91 | 82.32% | Maxim Group | Jason McCarthy | → $60 | Initiates | → Buy | Get Alert |
| 11/15/2023 | BLTE | Buy Now | Belite Bio | $32.91 | 79.28% | HC Wainwright & Co. | Yi Chen | → $59 | Reiterates | Buy → Buy | Get Alert |
| 11/07/2023 | BLTE | Buy Now | Belite Bio | $32.91 | 73.2% | Benchmark | Bruce Jackson | → $57 | Reiterates | Buy → Buy | Get Alert |
| 11/06/2023 | BLTE | Buy Now | Belite Bio | $32.91 | 79.28% | HC Wainwright & Co. | Yi Chen | $55 → $59 | Maintains | Buy | Get Alert |
| 08/10/2023 | BLTE | Buy Now | Belite Bio | $32.91 | 67.12% | HC Wainwright & Co. | Yi Chen | → $55 | Reiterates | Buy → Buy | Get Alert |
| 07/28/2023 | BLTE | Buy Now | Belite Bio | $32.91 | 30.66% | Cantor Fitzgerald | Jennifer Kim | → $43 | Initiates | → Overweight | Get Alert |
| 07/26/2023 | BLTE | Buy Now | Belite Bio | $32.91 | -24.04% | SVB Leerink | Marc Goodman | → $25 | Initiates | → Outperform | Get Alert |
| 07/25/2023 | BLTE | Buy Now | Belite Bio | $32.91 | 73.2% | Benchmark | Bruce Jackson | → $57 | Reiterates | Buy → Buy | Get Alert |
| 07/25/2023 | BLTE | Buy Now | Belite Bio | $32.91 | 67.12% | HC Wainwright & Co. | Yi Chen | → $55 | Reiterates | Buy → Buy | Get Alert |
| 06/20/2023 | BLTE | Buy Now | Belite Bio | $32.91 | 73.2% | Benchmark | Bruce Jackson | → $57 | Reiterates | Buy → Buy | Get Alert |
| 06/05/2023 | BLTE | Buy Now | Belite Bio | $32.91 | 67.12% | HC Wainwright & Co. | Yi Chen | $58 → $55 | Reiterates | → Buy | Get Alert |
| 04/04/2023 | BLTE | Buy Now | Belite Bio | $32.91 | 73.2% | Benchmark | Bruce Jackson | → $57 | Reiterates | → Buy | Get Alert |
| 04/04/2023 | BLTE | Buy Now | Belite Bio | $32.91 | 76.24% | HC Wainwright & Co. | Yi Chen | → $58 | Reiterates | → Buy | Get Alert |
| 02/22/2023 | BLTE | Buy Now | Belite Bio | $32.91 | 76.24% | HC Wainwright & Co. | Yi Chen | → $58 | Reiterates | → Buy | Get Alert |
| 02/21/2023 | BLTE | Buy Now | Belite Bio | $32.91 | 76.24% | HC Wainwright & Co. | Yi Chen | → $58 | Reiterates | → Buy | Get Alert |
| 08/01/2022 | BLTE | Buy Now | Belite Bio | $32.91 | 76.24% | HC Wainwright & Co. | Yi Chen | → $58 | Initiates | → Buy | Get Alert |
FAQ
What is the target price for Belite Bio (BLTE)?
The latest price target for Belite Bio (NASDAQ: BLTE) was reported by HC Wainwright & Co. on March 22, 2024. The analyst firm set a price target for $59.00 expecting BLTE to rise to within 12 months (a possible 79.28% upside). 14 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Belite Bio (BLTE)?
The latest analyst rating for Belite Bio (NASDAQ: BLTE) was provided by HC Wainwright & Co., and Belite Bio maintained their buy rating.
When was the last upgrade for Belite Bio (BLTE)?
There is no last upgrade for Belite Bio.
When was the last downgrade for Belite Bio (BLTE)?
There is no last downgrade for Belite Bio.
When is the next analyst rating going to be posted or updated for Belite Bio (BLTE)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Belite Bio, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Belite Bio was filed on March 22, 2024 so you should expect the next rating to be made available sometime around March 22, 2025.
Is the Analyst Rating Belite Bio (BLTE) correct?
While ratings are subjective and will change, the latest Belite Bio (BLTE) rating was a maintained with a price target of $59.00 to $59.00. The current price Belite Bio (BLTE) is trading at is $32.91, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.